BioTime (BTX) Posts Q3 EPS of 30c
Get Alerts BTX Hot Sheet
Join SI Premium – FREE
BioTime (NYSE: BTX) reported Q3 EPS of $0.30, which may not compare with the analyst estimate of ($0.14). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $1.23 million.
Profitability was largely due to a fain on equity method investment in Asterias at fair value.
For earnings history and earnings-related data on BioTime (BTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Super Micro Computer (SMCI) Falls 6%
- Acme United (ACU) Misses Q1 EPS by 20c
- Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!